mucopolysaccharidoses are a group of rare mostly autosomal recessive metabolic and genetic disorders. because of the high rate of consanguinity, they are not uncommon in our population. clinical diagnosis is not difficult for experienced physicians, but it is not enough for treatment and prevention measures in the future pregnancies. so, it is necessary to detect the type of mps by measurement ...

Through the development of advanced, stimulus-responsive pharmacological systems, protein engineering has potential to alter metabolic drug landscapes. Protein therapies are a fast growing category FDA-approved medications that have improve clinical consequences in long run. therapeutics is still its preliminary phase; however recent advancements skills being used gain direct monitoring over ph...